JiangXi Tianxin Pharm Co Ltd Total Liabilities

Latest as of March 2026: CN¥1.19 Billion CNY ≈ $174.27 Million USD

JiangXi Tianxin Pharm Co Ltd total liabilities. Based on the latest financial reports, JiangXi Tianxin Pharm Co Ltd (603235) has total liabilities worth CN¥1.19 Billion CNY (≈ $174.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of JiangXi Tianxin Pharm Co Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of JiangXi Tianxin Pharm Co Ltd (2020–2025)

Total liabilities of JiangXi Tianxin Pharm Co Ltd from 2020 to 2025. This chart illustrates how JiangXi Tianxin Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

JiangXi Tianxin Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of JiangXi Tianxin Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
SLC Agrícola S.A SA:SLCE3	Brazil	R$13.89 Billion
Shenzhen SDG Information Co Ltd SHE:000070	China	CN¥5.26 Billion
Long Young Electronic (Kunshan) Co. Ltd. A SHE:301389	China	CN¥807.77 Million
Reinsurance Group of America Inc NYSE:RZB	USA	$150.68 Billion
Ningxia Jiaze Renewables Corp SHG:601619	China	CN¥14.81 Billion
ConnectOne Bancorp, Inc. NASDAQ:CNOB	USA	$12.79 Billion
Sky Gold Limited NSE:SKYGOLD	India	Rs-12.06 Billion
KPIT Technologies Limited NSE:KPITTECH	India	Rs35.17 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down JiangXi Tianxin Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see JiangXi Tianxin Pharm Co Ltd asset portfolio.

Liquidity & Leverage Metrics

JiangXi Tianxin Pharm Co Ltd Total Liabilities Ratios Explained

JiangXi Tianxin Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	5.08	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how JiangXi Tianxin Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for JiangXi Tianxin Pharm Co Ltd (2020–2025)

The table below shows the annual total liabilities of JiangXi Tianxin Pharm Co Ltd from 2020 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.27 Billion ≈ $186.31 Million	+28.94%
2024-12-31	CN¥987.41 Million ≈ $144.49 Million	+15.19%
2023-12-31	CN¥857.21 Million ≈ $125.44 Million	+37.82%
2022-12-31	CN¥621.98 Million ≈ $91.02 Million	-40.40%
2021-12-31	CN¥1.04 Billion ≈ $152.71 Million	-40.72%
2020-12-31	CN¥1.76 Billion ≈ $257.61 Million	--

About JiangXi Tianxin Pharm Co Ltd

SHG:603235 China Packaged Foods

Market Cap

$1.59 Billion

CN¥10.87 Billion CNY

Market Cap Rank

#6790 Global

#1376 in China

Share Price

CN¥24.83

Change (1 day)

+0.32%

52-Week Range

CN¥22.00 - CN¥28.48

All Time High

CN¥50.78